160 related articles for article (PubMed ID: 32881226)
1. Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Iida H; Iga J; Hasegawa N; Yasuda Y; Yamamoto T; Miura K; Matsumoto J; Murata A; Ogasawara K; Yamada H; Hori H; Ichihashi K; Hashimoto N; Ohi K; Yasui-Furukori N; Tsuboi T; Nakamura T; Usami M; Furihata R; Takaesu Y; Iwamoto K; Sugiyama N; Kishimoto T; Tsujino N; Yamada H; Hishimoto A; Nemoto K; Atake K; Muraoka H; Katsumoto E; Oishi S; Inagaki T; Ito F; Imamura Y; Kido M; Nagasawa T; Numata S; Ochi S; Iwata M; Yamamori H; Fujita J; Onitsuka T; Yamamura S; Makinodan M; Fujimoto M; Takayanagi Y; Takezawa K; Komatsu H; Fukumoto K; Tamai S; Yamagata H; Kubota C; Horai T; Inada K; Watanabe K; Kawasaki H; Hashimoto R
Psychiatry Clin Neurosci; 2020 Dec; 74(12):667-669. PubMed ID: 32881226
[No Abstract] [Full Text] [Related]
2. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.
Nakamura T; Furihata R; Hasegawa N; Kodaka F; Muraoka H; Ichihashi K; Ochi S; Numata S; Tsuboi T; Makinodan M; Iida H; Onitsuka T; Kashiwagi H; Takeshima M; Hashimoto N; Nagasawa T; Usami M; Yamagata H; Takaesu Y; Miura K; Matsumoto J; Ohi K; Yamada H; Hori H; Inada K; Watanabe K; Hashimoto R; Yasui-Furukori N
BMC Psychiatry; 2024 May; 24(1):399. PubMed ID: 38807065
[TBL] [Abstract][Full Text] [Related]
3. Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Ichihashi K; Hori H; Hasegawa N; Yasuda Y; Yamamoto T; Tsuboi T; Iwamoto K; Kishimoto T; Horai T; Yamada H; Sugiyama N; Nakamura T; Tsujino N; Nemoto K; Oishi S; Usami M; Katsumoto E; Yamamori H; Tomita H; Suwa T; Furihata R; Inagaki T; Fujita J; Onitsuka T; Miura K; Matsumoto J; Ohi K; Matsui Y; Takaesu Y; Hashimoto N; Iga J; Ogasawara K; Yamada H; Watanabe K; Inada K; Hashimoto R
Neuropsychopharmacol Rep; 2020 Sep; 40(3):281-286. PubMed ID: 32602667
[TBL] [Abstract][Full Text] [Related]
4. Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Takaesu Y; Watanabe K; Numata S; Iwata M; Kudo N; Oishi S; Takizawa T; Nemoto K; Yasuda Y; Tagata H; Tsuboi T; Tsujino N; Hashimoto N; Matsui Y; Hori H; Yamamori H; Sugiyama N; Suwa T; Kishimoto T; Hishimoto A; Usami M; Furihata R; Iwamoto K; Fujishiro H; Nakamura T; Mizuno K; Inagaki T; Katsumoto E; Tomita H; Ohi K; Muraoka H; Atake K; Iida H; Nagasawa T; Fujita J; Yamamura S; Onitsuka T; Murata A; Takayanagi Y; Noda H; Matsumura Y; Takezawa K; Iga JI; Ichihashi K; Ogasawara K; Yamada H; Inada K; Hashimoto R
Psychiatry Clin Neurosci; 2019 Oct; 73(10):642-648. PubMed ID: 31437336
[TBL] [Abstract][Full Text] [Related]
5. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
Hasegawa N; Yasuda Y; Yasui-Furukori N; Yamada H; Hori H; Ichihashi K; Takaesu Y; Iida H; Muraoka H; Kodaka F; Iga JI; Hashimoto N; Ogasawara K; Ohi K; Fukumoto K; Numata S; Tsuboi T; Usami M; Hishimoto A; Furihata R; Kishimoto T; Nakamura T; Katsumoto E; Ochi S; Nagasawa T; Atake K; Kubota C; Komatsu H; Yamagata H; Ide K; Takeshima M; Kido M; Kikuchi S; Okada T; Matsumoto J; Miura K; Shimazu T; Inada K; Watanabe K; Hashimoto R
Psychiatry Clin Neurosci; 2023 Oct; 77(10):559-568. PubMed ID: 37684711
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.
Ichihashi K; Kyou Y; Hasegawa N; Yasui-Furukori N; Shimizu Y; Hori H; Hashimoto N; Ide K; Imamura Y; Yamada H; Ochi S; Iga JI; Takaesu Y; Ohi K; Tsuboi T; Iida H; Yamagata H; Hishimoto A; Horai T; Usami M; Makinodan M; Nagasawa T; Komatsu H; Kido M; Muraoka H; Atake K; Takeshima M; Kubota C; Inagaki T; Tamai S; Kishimoto T; Furihata R; Matsumoto J; Miura K; Inada K; Watanabe K; Kasai K; Hashimoto R
Asian J Psychiatr; 2022 Mar; 69():103007. PubMed ID: 35051727
[TBL] [Abstract][Full Text] [Related]
7. A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.
Yamada H; Motoyama M; Hasegawa N; Miura K; Matsumoto J; Ohi K; Yasui-Furukori N; Numata S; Takeshima M; Sugiyama N; Nagasawa T; Kubota C; Atake K; Tsuboi T; Ichihashi K; Hashimoto N; Inagaki T; Takaesu Y; Iga JI; Hori H; Onitsuka T; Komatsu H; Hishimoto A; Fukumoto K; Fujimoto M; Nakamura T; Nemoto K; Furihata R; Yamamura S; Yamagata H; Ogasawara K; Katsumoto E; Murata A; Iida H; Ochi S; Makinodan M; Kido M; Kishimoto T; Yasuda Y; Usami M; Suwa T; Inada K; Watanabe K; Hashimoto R
BJPsych Open; 2022 Apr; 8(3):e83. PubMed ID: 35446248
[TBL] [Abstract][Full Text] [Related]
8. Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.
Iida H; Okada T; Nemoto K; Hasegawa N; Numata S; Ogasawara K; Miura K; Matsumoto J; Hori H; Iga JI; Ichihashi K; Hashimoto N; Yamada H; Ohi K; Yasui-Furukori N; Fukumoto K; Tsuboi T; Usami M; Furihata R; Takaesu Y; Hishimoto A; Muraoka H; Katsumoto E; Nagasawa T; Ochi S; Komatsu H; Kikuchi S; Takeshima M; Onitsuka T; Tamai S; Kubota C; Inada K; Watanabe K; Kawasaki H; Hashimoto R
Neuropsychopharmacol Rep; 2023 Mar; 43(1):23-32. PubMed ID: 36444167
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
Hashimoto N; Yasui-Furukori N; Hasegawa N; Ishikawa S; Numata S; Hori H; Iida H; Ichihashi K; Furihata R; Murata A; Tsuboi T; Takeshima M; Kyou Y; Komatsu H; Kubota C; Ochi S; Takaesu Y; Usami M; Nagasawa T; Hishimoto A; Miura K; Matsumoto J; Ohi K; Yamada H; Inada K; Watanabe K; Shimoda K; Hashimoto R
Asian J Psychiatr; 2021 Sep; 63():102744. PubMed ID: 34325252
[TBL] [Abstract][Full Text] [Related]
10. The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
Kyou Y; Yasui-Furukori N; Hasegawa N; Ide K; Ichihashi K; Hashimoto N; Hori H; Shimizu Y; Imamura Y; Muraoka H; Iida H; Ohi K; Yasuda Y; Ogasawara K; Numata S; Iga JI; Tsuboi T; Ochi S; Kodaka F; Furihata R; Onitsuka T; Makinodan M; Komatsu H; Takeshima M; Kubota C; Hishimoto A; Atake K; Yamagata H; Kido M; Nagasawa T; Usami M; Kishimoto T; Kikuchi S; Matsumoto J; Miura K; Yamada H; Watanabe K; Inada K; Hahimoto R
Ann Gen Psychiatry; 2022 Dec; 21(1):52. PubMed ID: 36567327
[TBL] [Abstract][Full Text] [Related]
11. Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.
Hashimoto N; Yasui-Furukori N; Hasegawa N; Ishikawa S; Hori H; Iida H; Ichihashi K; Miura K; Matsumoto J; Numata S; Kodaka F; Furihata R; Ohi K; Ogasawara K; Iga JI; Muraoka H; Komatsu H; Takeshima M; Atake K; Kido M; Nakamura T; Kishimoto T; Hishimoto A; Onitsuka T; Okada T; Ochi S; Nagasawa T; Makinodan M; Yamada H; Tsuboi T; Yamada H; Inada K; Watanabe K; Hashimoto R
BMC Psychiatry; 2023 Jun; 23(1):473. PubMed ID: 37380997
[TBL] [Abstract][Full Text] [Related]
12. Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
Numata S; Nakataki M; Hasegawa N; Takaesu Y; Takeshima M; Onitsuka T; Nakamura T; Edagawa R; Edo H; Miura K; Matsumoto J; Yasui-Furukori N; Kishimoto T; Hori H; Tsuboi T; Yasuda Y; Furihata R; Muraoka H; Ochi S; Nagasawa T; Kyou Y; Murata A; Katsumoto E; Ohi K; Hishimoto A; Inada K; Watanabe K; Hashimoto R
Neuropsychopharmacol Rep; 2021 Jun; 41(2):199-206. PubMed ID: 33704931
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy in Belgium: a nationwide survey on the practice of electroconvulsive therapy.
Sienaert P; Dierick M; Degraeve G; Peuskens J
J Affect Disord; 2006 Jan; 90(1):67-71. PubMed ID: 16337689
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study.
Sisay M; Mengistu G; Molla B; Amare F; Gabriel T
BMC Health Serv Res; 2017 Feb; 17(1):161. PubMed ID: 28231833
[TBL] [Abstract][Full Text] [Related]
15. Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression.
Case BG; Bertollo DN; Laska EM; Price LH; Siegel CE; Olfson M; Marcus SC
Biol Psychiatry; 2013 Nov; 74(10):e19-20. PubMed ID: 23786984
[No Abstract] [Full Text] [Related]
16. Analysis of drug prescriptions in primary health care centres in Bahrain.
Otoom S; Culligan K; Al-Assoomi B; Al-Ansari T
East Mediterr Health J; 2010 May; 16(5):511-5. PubMed ID: 20799550
[No Abstract] [Full Text] [Related]
17. Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.
Slade EP; Jahn DR; Regenold WT; Case BG
JAMA Psychiatry; 2017 Aug; 74(8):798-804. PubMed ID: 28658489
[TBL] [Abstract][Full Text] [Related]
18. Effect of Age on Psychiatric Rehospitalization Rates After Electroconvulsive Therapy for Patients With Depression.
Rosen BH; Kung S; Lapid MI
J ECT; 2016 Jun; 32(2):93-8. PubMed ID: 26308147
[TBL] [Abstract][Full Text] [Related]
19. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
20. [Psychiatric polypharmacy and electroconvulsive therapy in treatment-resistant depression].
Zöllner R; Huber MT; Mangelsdorf C; Konrad C; Zavorotnyy M
Nervenarzt; 2020 Jul; 91(7):624-634. PubMed ID: 31489462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
